Brisbane Clinical Trials
The Elevation Study
The study drug is a potential new treatment for hypertriglyceridemia or elevated levels of triglyceride (a type of fat) in the blood.
2 sets of 3 nights
2 screening + 12 outpatient visits
There are currently treatments available that reduce the levels of triglycerides in patients, but they also have a risk of leading to low platelet count.
Because this medical condition affects up to 10% of adults worldwide, there is a demand for more and more effective treatments with fewer side effects.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Eligibility
Biological Sex Male or Female
Age 18– 65 years old
BMI 18 - 32 kg/m²
Medical History No significant medical history (current high cholesterol is permitted)
Medications Not taking any prescription medication (except for hormonal contraception)
Smoking History Non-smokers and social smokers only (<4 cigarettes/day)